The page is the record's research on the issuer — no analyst, no rating, no view.

# Noile-Immune Biotech Inc. (Growth Market: 4893) — research page

As of 2026-11-06 · jp-cm-kg · record version 1

## Identity and listing

The issuer is Noile-Immune Biotech Inc., listed on the Growth Market under ticker 4893. The ISIN is not on the record. The LEI is not on the record. The security type is Corporate. The segment is not on the record. The sector is 3250 Pharmaceutical. The jurisdiction is Japan (EDINET domestic filer). The listing status is listed, not halted.

## The disclosure read

The record holds 6 filings in the twelve months to 2026-11-06, across 3 filing days. The filings comprise 1 ad hoc, 3 regulatory filings and 2 results. The median gap between filing days is 71.5 days. The latest filing is dated 2026-08-13, is of type regulatory filing, and is 85 days before the record date. The Growth Market median cadence is 42 days across 598 issuers, with a median of 8.0 filings and a median latency of 85.0 days. The 3250 Pharmaceutical sector median cadence is 49.5 days across 80 issuers, with a median of 8.0 filings and a median latency of 85.0 days.

## Auditor

The auditor of record is 有限責任監査法人トーマツ. Its location is not on the record. Auditor changes are not on the record.

## Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, as the market has no lifecycle type map yet. The issuer is listed and not halted.

## Orderability

For Qualified Institutional Investors, the outcome is not determinable. The rule states a product scope, the subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.

## Coverage

No research houses were found on the issuer's investor-relations pages read.

## Open research

One openly published research note is on the record, by FISCO Ltd., dated 2025-05-26.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The vintage is not sealed. No issuer years are sealed. The market's earliest sealed date is not on the record, and the live record began is not on the record.

## Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)
- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)
- https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4893 (the disclosure lines)
- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)
- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XSP4 (the auditor)
- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)
- https://www.fisco.co.jp/wordpress/wp-content/uploads/FISCO/noile-immune20250526.pdf (open research)
- https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4893 (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/jp/TSE-GROWTH/4893 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
